Psilera Bioscience Announces Award-Winning Executive Team and Flagship Patent Milestone for Future Psychedelic Therapies Post published:July 1, 2020 Post category:Press Release
Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board Post published:June 30, 2020 Post category:Press Release
Osoyoos Announces Closing of Acquisition of AI Pharmaceuticals Jamaica Limited Post published:June 30, 2020 Post category:Press Release
Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19 Post published:June 30, 2020 Post category:Press Release
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry Post published:June 29, 2020 Post category:Press Release
Cybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead Concurrent Private Placement of up to $21M Post published:June 29, 2020 Post category:Press Release
Clarmin Explorations Inc. Enters Into Amalgamation Agreement for Reverse Takeover With Cybin Corp. Post published:June 29, 2020 Post category:Press Release
Osoyoos Announces Agreement to Acquire AI Pharmaceuticals Jamaica Limited Post published:June 27, 2020 Post category:Press Release
Numinus Wellness Inc. Engages Venture Liquidity Providers and Mackie Research for Market Making Services Post published:June 27, 2020 Post category:Press Release